Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Amortizatization of Intangibles (2021 - 2025)

Invivyd's (IVVD) quarterly Amortizatization of Intangibles came in at $286000.0 in Q4 2025, down 33.8% on a YoY basis from $432000.0 in Q4 2024, and up 1.42% quarter-over-quarter from $282000.0 in Q3 2025.

Analysis

Invivyd (IVVD) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends

Invivyd (IVVD) has reported Amortizatization of Intangibles for 5 consecutive years, with $286000.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 33.8% year-over-year to $286000.0; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (down 17.91% YoY), and the FY2025 full-year result was $1.4 million, down 17.91% from the prior year.
  • Amortizatization of Intangibles advanced to $286000.0 in Q4 2025 per IVVD's latest filing, from $282000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.5 million in Q1 2023 and bottomed at -$4.7 million in Q4 2023.
  • Historically, Amortizatization of Intangibles has averaged $285555.6 across 5 years, with a median of $403500.0 in 2022.
  • The widest YoY moves for Amortizatization of Intangibles: up 5358.06% in 2023, down 364.35% in 2023.
  • Over 5 years, Amortizatization of Intangibles stood at -$2.0 million in 2021, then jumped by 188.74% to $1.8 million in 2022, then slumped by 364.35% to -$4.7 million in 2023, then soared by 109.18% to $432000.0 in 2024, then sank by 33.8% to $286000.0 in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $286000.0, $282000.0, and $352000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 600.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 678,000.00
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 286,000.00
Sep 30, 2025 282,000.00
Jun 30, 2025 352,000.00
Mar 31, 2025 432,000.00
Dec 31, 2024 432,000.00
Sep 30, 2024 427,000.00
Jun 30, 2024 386,000.00
Mar 31, 2024 402,000.00
Dec 31, 2023 -4.71 Mn
Sep 30, 2023 1.69 Mn
Jun 30, 2023 2.02 Mn
Mar 31, 2023 2.54 Mn
Dec 31, 2022 1.78 Mn
Sep 30, 2022 31,000.00
Jun 30, 2022 405,000.00
Mar 31, 2022 -194,000.00
Dec 31, 2021 -2.01 Mn
Sep 30, 2021 577,000.00